We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

5,964.502 days ago
6,285.002 days ago
arrow

LOWER/UPPER CIRCUITS

5,594.00
6,837.00
arrow
Divis Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 15.13%
Net profit growth 5Y CAGR : 3.41%

STOCK RETURNS

info
Versus Nifty 50
1 w
+5.04%
vs
+2%
1 mth
+0.23%
vs
+2.83%
3 mth
+2.81%
vs
+5.36%
6 mth
+3.27%
vs
-0.29%
1 yr
+55.34%
vs
+8.6%
3 yr
+31.88%
vs
+41.68%
5 yr
+144.27%
vs
+165.76%
Divis Laboratories Ltd Top mutual funds holding
arrow
Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world. The company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
personal

Grow your wealth with more research recommendations

+91